Asylia Diagnostics Company

Asylia Diagnostics - precision medicine data platform for immunotherapies

Employee Number: 45200
Last Funding Type: Series B
Funding Status: Seed
Total Funding: 1100000.0
Last Funding Date: 2020-03-02
Industry: Medical BioTech
Estimated Revenue: Less than $1M
Investors Number: 2.0
Founded Date: 2019-08-22
Technology: ['BioTech & HealthTech']
Investor Type: andrey.khmelevskiy@asyliadx.com
Headquarters: Delaware City, Delaware, United States